Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-20-017268

EVP, Chief Technology Officer acquired 1,209 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lingamneni Anila · EVP, Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-18 Grant or award : show line 1 in the form +1,209 3,390 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-18 Grant or award : show line 2 in the form Non-qualified Stock Option (Right to Buy) +4,092 4,092 D
Loading xslF345X03/form4.xml…